🇺🇸 FDA
Patent

US 10278986

Antibody-siRNA conjugates and uses therefor

granted A61KA61K2039/505A61K31/7088

Quick answer

US patent 10278986 (Antibody-siRNA conjugates and uses therefor) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K31/7088, A61K39/3955, A61K47/6807